Loading clinical trials...
Loading clinical trials...
This study has been designed as a randomized controlled trial including women invited to a national screening program for breast cancer in Norway, BreastScreen Norway in 2025. The program invites wome...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Norwegian Institute of Public Health
NCT07075679 · Breast Cancer Screening, Artificial Intelligence (AI), and more
NCT06934239 · Breast Cancer Screening, Artificial Intelligence (AI)
NCT02620852 · Breast Cancer Screening, Breast Carcinoma in Situ, and more
NCT01900821 · Breast Cancer Screening and Diagnosis
NCT07472036 · Health Behavior, Breast Cancer Screening, and more
Norwegian Institute of Public Health
Oslo, Oslo
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions